(Q39444314)

12 September 2017

Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). (English)

1 reference

12 September 2017

1 reference

Leishmania donovani

1 reference

Francisco Gamarro

5

0 references

author name string

Karin Seifert

1

1 reference

12 September 2017

Sangeeta Matu

2

1 reference

12 September 2017

F Javier Pérez-Victoria

3

1 reference

12 September 2017

Santiago Castanys

4

1 reference

12 September 2017

Simon L Croft

6

1 reference

12 September 2017

1 October 2003

1 reference

12 September 2017

8

1 reference

International Journal of Antimicrobial Agents

inferred from page(s)

published in

1 reference

12 September 2017

22

1 reference

12 September 2017

4

1 reference

12 September 2017

380-387

1 reference

Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Chemotherapy of leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Hexadecylphosphocholine: a new and selective antitumor drug

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Analogs of alkyllysophospholipids: chemistry, effects on the molecular level and their consequences for normal and malignant cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Short-course of oral miltefosine for treatment of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Mechanisms of action of phospholipid analogs as anticancer compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Effects of miltefosine on various biochemical parameters in a panel of tumor cell lines with different sensitivities

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: potentiation of in vitro activity by the sterol biosynthesis inhibitor ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Ether--lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether--lipid analogues in Leishmania

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Down-regulation of Leishmania donovani trypanothione reductase by heterologous expression of a trans-dominant mutant homologue: effect on parasite intracellular survival

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Altered drug membrane permeability in a multidrug-resistant Leishmania tropica line.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Separation of large DNA molecules by contour-clamped homogeneous electric fields

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Involvement of thiol metabolism in resistance to glucantime in Leishmania tropica

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Gene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Cytotoxicity of ester and ether lysophospholipids on Leishmania donovani promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Metabolism of ether lysophospholipids in Leishmania donovani promastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Induction of resistance to hexadecylphosphocholine in the highly sensitive human epidermoid tumour cell line KB.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

MDR1 causes resistance to the antitumour drug miltefosine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Bcl-2 plays a key role instead of mdr1 in the resistance to hexadecylphosphocholine in human epidermoid tumor cell line KB.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Linear amplicons as precursors of amplified circles in methotrexate-resistant Leishmania tarentolae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Co-existence of circular and multiple linear amplicons in methotrexate-resistant Leishmania

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Amplification of ABC transporter gene pgpA and of other heavy metal resistance genes in Leishmania tarentolae and their study by gene transfection and gene disruption.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Drug resistance and P-glycoprotein gene amplification in the protozoan parasite Leishmania

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdr1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

Leishmania amazonensis: multidrug resistance in vinblastine-resistant promastigotes is associated with rhodamine 123 efflux, DNA amplification, and RNA overexpression of a Leishmania mdr1 gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900125-0

7 January 2021

10.1016/S0924-8579(03)00125-0

Identifiers

DOI

1 reference

12 September 2017

1 reference